BioMarin to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will participate in two virtual investor conferences: the Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020, at 10:55 AM ET and the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 1:00 PM ET. Key executives, including Jeff Ajer and Brian Mueller, will represent the company. Live audio webcasts will be accessible on their investor relations website, with archived versions available afterwards. BioMarin focuses on innovative therapies for serious rare disorders.

SAN RAFAEL, Calif., Aug. 10, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jeff Ajer, Executive Vice President and Chief Commercial Officer, and Brian Mueller, Executive Vice President, Chief Financial Officer will participate in the 2020 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020 at 10:55am ET and Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020 at 1:00pm ET.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301108236.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What virtual conferences will BioMarin participate in?

BioMarin will participate in the Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020, and the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020.

Who are the key executives attending the BioMarin conferences?

Jeff Ajer, Brian Mueller, and Henry Fuchs will attend the upcoming virtual conferences.

When will the BioMarin presentations take place?

The Wedbush conference is on August 11, 2020, at 10:55 AM ET, and the Canaccord Genuity conference is on August 13, 2020, at 1:00 PM ET.

Where can I watch the BioMarin conference presentations?

The presentations can be accessed live via BioMarin's investor relations website, with archived versions available afterwards.

What is BioMarin's focus in the biotechnology sector?

BioMarin develops innovative therapies for people with serious and life-threatening rare disorders.